Phyto Partners is a venture capital firm based in Boca Raton, Florida. The firm focuses on investing in privately-held businesses that operate within and around the cannabis industry, including sectors such as education, branded products, agriculture technology, point of sale software, advertising technology, and biotechnology. With a strategic approach, they provide venture capital to early industry operators and have contributed to the growth of the cannabis industry from $4 billion in sales in 2015 to nearly $25 billion in 2021. Expanding their investment thesis, Phyto Partners has identified an emerging opportunity paralleling the early years of legal cannabis: the brain health megatrend. The firm believes that the significance of mental wellness has reached a pivotal point, whereby taking care of one's mind is becoming as essential as taking care of the body. Leveraging their experience, they have launched the Phyto Psyche Fund, a new psychedelic-focused fund, aiming to replicate their success in the cannabis sector by investing in the neurowellness space. The fund is structured to recognize and capitalize on what they see as a burgeoning brain health megatrend, providing venture capital to companies at the forefront of this movement. Phyto Partners notes that this megatrend has not yet been widely acknowledged by the financial community, presenting a unique investment opportunity. Through their funds, Phyto Partners continues to invest in and support innovative companies that contribute to industry growth and meet their investment criteria.